![](/img/cover-not-exists.png)
Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence
Ham, Janneke C., Meerten, Esther, Fiets, W. Edward, Beerepoot, Laurens V., Jeurissen, Frank J. F., Slingerland, Marije, Jonker, Marianne A., Husson, Olga, Graaf, Winette T. A., Herpen, Carla M. L.Journal:
Head & Neck
DOI:
10.1002/hed.26053
Date:
January, 2020
File:
PDF, 1.09 MB
2020